Metabolic score for insulin resistance

There are 54 papers on metabolic score for insulin resistance in aging research: 1 trial and 52 observational studies in people, 1 review.

Biomarker

54 papers study it80 more mention it35 findings

16 new papers in 30 daysSee all 134 papers on metabolic score for insulin resistance

“METS-IR exhibited the strongest association with overall LC, with the highest quartile associated with an increased risk”
Association between four indirect indicators of insulin resistance and lung cancer: evidence from UK biobank and Mendelian randomization analysisBMC cancer2026doi:10.1186/s12885-026-15697-w
  • Human trial1
  • Humans52

Effects

1

Kidney stone disease risk reclassification

upin humans1

1 study
  1. Metabolic score for insulin resistance is linked with better kidney stone disease risk reclassification in humans (Compared with body mass index alone) (NRI 0.107, 95% CI 0.011–0.196).

    “METS-IR provided a significant incremental risk reclassification benefit over body mass index (BMI) alone (NRI =0.107, 95% CI: 0.011-0.196).”

    HumansCompared with body mass index alone54.2% malesn = 39,305

    Association between metabolic score for insulin resistance trajectories and the risk of kidney stone disease: a retrospective cohort study

    Translational andrology and urology

Upstream

1

Physical capability

downin humans1

1 study
  1. Physical capability is linked with lower metabolic score for insulin resistance in humans (both P ≤ 0.03).

    “increases in walking speed or grip strength were related to reduced metabolic score for insulin resistance (both P ≤ 0.03).”

    Humans4 yearsn = 1,667

    Changes in objectively-measured physical capability over 4-year, risk of diabetes, and glycemic control in older adults: The China Health and Retirement Longitudinal study

    Diabetes research and clinical practice

Associations

25

Cardiovascular mortality

upin humans2mixedin humans1HR 1.29–1.91

3 studies
  1. Metabolic score for insulin resistance predicts cardiovascular mortality in humans (Peritoneal dialysis patients with end-stage renal disease; exploratory METS-IR cutoff 33.3) (AUC 0.617 (95% CI 0.557–0.677); sensitivity 75.3%, specificity 48.3% at cutoff 33.3).

    “with an AUC (95% CI) of 0.617 (0.557–0.677; p < 0.001), indicating modest discrimination.”

    HumansPeritoneal dialysis patients with end-stage renal disease; exploratory METS-IR cutoff 33.3n = 553

    Associations of metabolic score for insulin resistance (METS-IR) with cardiovascular mortality risk in peritoneal dialysis patients

    PloS one

  2. Metabolic score for insulin resistance is associated with cardiovascular mortality in humans (Highest versus lowest tertile: HR 1.91 (95% CI 1.03–3.55); second versus lowest tertile: HR 1.90 (95% CI 1.01–3.61)).

    “those in tertile 3 was associated with an HR of 1.91 (95% CI, 1.03–3.55) compared with tertile 1.”

    HumansPeritoneal dialysis patients with end-stage renal disease; highest versus lowest METS-IR tertile, fully adjusted modeln = 553

    Associations of metabolic score for insulin resistance (METS-IR) with cardiovascular mortality risk in peritoneal dialysis patients

    PloS one

  3. Metabolic score for insulin resistance is associated with cardiovascular mortality in humans (Cardiovascular patients with cardiometabolic conditions; METS-IR above 48.9) (HR 1.29, 95% CI 1.04–1.61 above threshold 48.9).

    “Above their respective inflexion points, both markers demonstrated a positive correlation with CV mortality”

    HumansCardiovascular patients with cardiometabolic conditions; METS-IR above 48.9Average follow-up, 7.6±6.7 years78.8% malesn = 1,720

    Nonlinear association of TyG index and METS-IR with cardiovascular mortality in cardiometabolic patients: a long-term cohort study

    ESC Congress 2026 abstract

  4. Metabolic score for insulin resistance is associated with cardiovascular mortality in humans (cardiovascular–kidney–metabolic syndrome stage 2) (U-shaped association; risk rose sharply above METS-IR ≈ 46.8).

    “TyG and METS-IR exhibited U-shaped curves: risk rose sharply above TyG = 8.78 and METS-IR ≈ 46.8.”

    Humanscardiovascular–kidney–metabolic syndrome stage 2Median follow-up of 103 monthsn = 13,098

    Insulin-resistance indices and cardiovascular mortality in cardiovascular-kidney-metabolic syndrome stage 2: a comparative analysis of eGDR, TyG and METS-IR

    Diabetology & metabolic syndrome

Cardiometabolic multimorbidity

upin humans2OR 7.89

2 studies
  1. Metabolic score for insulin resistance predicts cardiometabolic multimorbidity in humans (CHARLS cohort) (AUC = 0.712).

    “METS-IR had moderate predictive value (AUC = 0.712 in CHARLS, 0.618 in clinical data), outperforming CCR.”

    HumansCHARLS cohort

    Cardiometabolic multimorbidity in relation to the metabolic score for insulin resistance and creatinine-to-cystatin C ratio in a middle-aged and aged population

    Frontiers in endocrinology

  2. Metabolic score for insulin resistance is linked with a higher risk of cardiometabolic multimorbidity in community and clinical cohorts.

    “METS-IR was independently and dose-dependently associated with increased CMM risk.”

    Humansin community and clinical cohorts

    Cardiometabolic multimorbidity in relation to the metabolic score for insulin resistance and creatinine-to-cystatin C ratio in a middle-aged and aged population

    Frontiers in endocrinology

  3. Metabolic score for insulin resistance is associated with cardiometabolic multimorbidity in humans (Hypertensive patients; adjusted for confounding factors) (OR 7.89 (95% CI 6.76–9.22)).

    “higher METS-VF, METS-IR, and CMI were all risk factors for CMM”

    HumansHypertensive patients; adjusted for confounding factorsn = 16,303

    The correlation between different metabolic scores and the risk of cardiometabolic comorbidities in hypertensive patients

    Scientific reports

More on Cardiometabolic multimorbidity

Lung cancer

upin humans1downin humans1HR 0.8–1.24

2 studies
  1. Metabolic score for insulin resistance is associated with lung cancer in humans (Highest METS-IR quartile; fully adjusted Cox regression) (HR 1.24, 95% CI 1.05–1.47).

    “METS-IR exhibited the strongest association with overall LC, with the highest quartile associated with an increased risk”

    HumansHighest METS-IR quartile; fully adjusted Cox regressionMedian follow-up of 13.25 yearsn = 388,013

    Association between four indirect indicators of insulin resistance and lung cancer: evidence from UK biobank and Mendelian randomization analysis

    BMC cancer

  2. Metabolic score for insulin resistance is linked with a lower risk of lung cancer in humans (fully adjusted Cox regression model) (HR 0.80, 95% CI 0.74-0.86; p for trend < 0.001).

    “In fully adjusted Cox regression models, using Q1 as the reference group, higher METS-IR quartiles were associated with a significantly lower risk of lung cancer”

    Humansfully adjusted Cox regression modelQ4 vs Q19.5 years median follow-upn = 322,624

    Inverse Association Between METS-IR and Lung Cancer Risk: The Role of BMI in a Nationwide Korean Cohort

    Cancers

More on Lung cancer

Mild cognitive impairment

mixedin humans1downin humans1HR 0.65

1 study
  1. Metabolic score for insulin resistance is associated with mild cognitive impairment in humans (overall sample, nonlinear analysis).

    “Restricted cubic spline analyses showed a significant nonlinear association between METS-IR and incident MCI in the overall sample (P for overall < .001, P for nonlinear = .017).”

    Humansoverall sample, nonlinear analysisn = 4,980

    Substitutional value of METS-IR for biochemical components of life's essential 8 in predicting incident mild cognitive impairment: A longitudinal cohort study

    Medicine

  2. Metabolic score for insulin resistance is linked with a lower risk of mild cognitive impairment in humans (quartile 3 vs quartile 1) (HR 0.65, 95% CI 0.53-0.78).

    “hazard ratios for incident MCI were 0.94 (95% confidence interval [CI]: 0.79-1.11) for quartile 2, 0.65 (95% CI: 0.53-0.78) for quartile 3, and 0.72 (95% CI: 0.59-0.87) for quartile 4.”

    Humansquartile 3 vs quartile 1n = 4,980

    Substitutional value of METS-IR for biochemical components of life's essential 8 in predicting incident mild cognitive impairment: A longitudinal cohort study

    Medicine

More on Mild cognitive impairment

Dyslipidemia

upin humans1

1 study
  1. Metabolic score for insulin resistance is linked with a higher risk of dyslipidemia in humans (longitudinal analysis) (P for trend < 0.05).

    “In longitudinal analysis, TyG, TyG-BMI, TyG-WC, TyG-WHtR, METS-IR, and TG/HDL-C were positively associated with the risk of new-onset dyslipidaemia (P for trend < 0.05).”

    Humanslongitudinal analysismedian 1,874 daysn = 1,033

    Comparison of the predictive power of novel insulin resistance, lipid metabolism and obesity indices for the risk of developing dyslipidaemia in adults

    BMC endocrine disorders

  2. Metabolic score for insulin resistance predicts dyslipidemia in humans (longitudinal analysis) (importance score 0.105).

    “feature importance assessment and Shapley additive interpretation (SHAP) analysis further confirmed METS-IR as the best predictor of dyslipidemia with an importance score of 0.105.”

    Humanslongitudinal analysismedian 1,874 daysn = 1,033

    Comparison of the predictive power of novel insulin resistance, lipid metabolism and obesity indices for the risk of developing dyslipidaemia in adults

    BMC endocrine disorders

More on Dyslipidemia

White matter hyperintensity burden

upin humans1

1 study
  1. Metabolic score for insulin resistance is associated with white matter hyperintensity burden in humans after adjustment for demographic, socioeconomic, lifestyle and vascular risk factors.

    “Higher METS-IR was associated with greater WMH burden after adjustment for demographic, socioeconomic, lifestyle and vascular risk factors.”

    Humansafter adjustment for demographic, socioeconomic, lifestyle and vascular risk factorsbrainn = 59,826

    Association of metabolic insulin resistance with white matter hyperintensity burden and plasma proteomic signatures in the UK Biobank

    The International journal of neuroscience

More on White matter hyperintensity burden

Metabolic dysfunction-associated steatotic liver disease

upin humans1OR 3.65

1 study
  1. Metabolic score for insulin resistance is associated with metabolic dysfunction-associated steatotic liver disease in humans (Adjusted OR 3.65 in Chinese participants and 2.90 in Japanese participants; all P < 0.001).

    “Fully adjusted odds ratios per standard deviation increase in TyG, TyG-BMI, METS-IR and SPISE were 2.39, 5.09, 3.65 and 0.15 in the Chinese cohort”

    HumansNonobese Chinese longitudinal and Japanese cross-sectional cohorts; per standard deviation increase

    Comparison of four insulin resistance surrogate indices for incident MASLD in Chinese and prevalent MASLD in Japanese nonobese adults

    Scientific reports

More on Metabolic dysfunction-associated steatotic liver disease

Progression to stage 4 cardiovascular-kidney-metabolic syndrome

upin humans1HR 1.11

1 study
  1. Metabolic score for insulin resistance is associated with progression to stage 4 cardiovascular-kidney-metabolic syndrome in humans (Baseline cardiovascular–kidney–metabolic syndrome stages 0–3; fully adjusted model) (HR 1.11 per 1-SD increase (95% CI 1.07–1.14); fourth versus first quartile HR 2.03 (95% CI 1.64–2.52); p for trend <0.001).

    “each 1-standard-deviation increase in METS-IR was associated with a hazard ratio of 1.11 (95% confidence interval, 1.07–1.14)”

    HumansBaseline cardiovascular–kidney–metabolic syndrome stages 0–3; fully adjusted modelEach 1-standard-deviation increaseMedian 7-year follow-upn = 31,286

    Metabolic Score for Insulin Resistance and Progression to Stage 4 of Cardiovascular–Kidney–Metabolic Syndrome: A Retrospective Cohort Study

    Medicina (Kaunas, Lithuania)

More on Progression to stage 4 cardiovascular-kidney-metabolic syndrome

sRAGE

mixedin humans1

1 study
  1. Metabolic score for insulin resistance is associated with sRAGE in humans (Biomarker subset; accounting for HOMA-IR).

    “Of these, HOMA-IR, sex, age, SBP, lipid-lowering medication, sRAGE and leptin remained significantly correlated to METS-IR.”

    HumansBiomarker subset; accounting for HOMA-IRplasma33% mens

    The metabolic score for insulin resistance (METS-IR) predicts MACE and is correlated to plasma levels of leptin and sRAGE: validation and mechanistic insights from a Swedish population-based cohort

    ESC Congress 2026 abstract

More on sRAGE

Leptin

mixedin humans1

1 study
  1. Metabolic score for insulin resistance is associated with leptin in humans (Biomarker subset; accounting for HOMA-IR).

    “Of these, HOMA-IR, sex, age, SBP, lipid-lowering medication, sRAGE and leptin remained significantly correlated to METS-IR.”

    HumansBiomarker subset; accounting for HOMA-IRplasma33% mens

    The metabolic score for insulin resistance (METS-IR) predicts MACE and is correlated to plasma levels of leptin and sRAGE: validation and mechanistic insights from a Swedish population-based cohort

    ESC Congress 2026 abstract

More on Leptin

All 25

Latest

Dec 2025: 9Jan 2026: 11Feb 2026: 15Mar 2026: 7Apr 2026: 3May 2026: 2Jun 2026: 3Jul 2026: 7Aug 2026: 5Sep 2026: 7Oct 2026: 16Nov 2026: 590 papers in 12 months

See all 134 papers on metabolic score for insulin resistance